William Desmarais
No más puestos en curso
Perfil
William Desmarais served as Vice President-Business Development at Momenta Pharmaceuticals, Inc. from 2017 to 2021.
He then worked as Chief Business Officer at TScan Therapeutics, Inc. from 2021 to 2023.
Desmarais holds an MBA from Massachusetts Institute of Technology, a doctorate from Brandeis University, and an undergraduate degree from Purdue University.
Antiguos cargos conocidos de William Desmarais.
| Empresas | Cargo | Fin |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2023 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2021 |
Formación de William Desmarais.
| Brandeis University | Doctorate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
| Purdue University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- William Desmarais